Skip to search formSkip to main contentSkip to account menu

Metastatic Disease Clinical Trial Setting

Known as: METASTATIC 
A clinical trial or treatment setting in which the therapy of interest is used to treat metastatic disease.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
3503Background: The incidence of SCCA continues to rise annually in the US. 20% of patients (pts) will develop metastatic (met… 
2014
2014
This is a case study of a female patient diagnosed with superficial spreading melanoma who decided to treat the lesion by the… 
2011
2011
1009 Background: SOR, a multikinase inhibitor targeting tumor growth and angiogenesis, is indicated for adv renal and… 
2011
2011
Mitoxantrone plus prednisone and ixabepilone each have modest activity as monotherapy for second‐line chemotherapy in patients… 
2010
2010
Soft tissue sarcoma (STS) comprises a large variety of rare malignant tumors. Development of distant metastasis is frequent, even… 
Review
2008
Review
2008
Colorectal cancer continues to be an important public health concern, despite improvements in screening and better systemic… 
Review
2007
Review
2007
2017 Background: The outcome for patients with metastatic medulloblastoma has historically been poor. Carboplatin is both a… 
2005
2005
3040 Background: SU11248 is an oral, multitargeted kinase inhibitor with antiangiogenic and antitumor activity due to inhibition…